“Cancer has no geographic boundaries,” said Dr. Tolcher, CEO and founder of NEXT Oncology. “One of the continuing challenges has been that cancer research has been conducted in silos. Our goal has always been to break down those barriers and bring potentially life-saving therapies to people in other cities within Texas, while at the same time expediting the development of new …
Research remains an essential part of cancer care. In this blog, we will provide information about recent updates or new approvals as it applies to breast cancer written by Dr. Sharon Wilks. Recently, there was an update on the AMAROS trial that now has 10-year results. In order to have perspective on this report, it is important to know that …
Research remains an essential part of cancer care. In this blog, we will provide information about recent updates or new approvals as it applies to breast cancer written by Dr. Sharon Wilks. Oserdu, an Oral SERD, was recently FDA approved for Recurrent Metastatic Hormone Receptor Positive Breast cancer with ESR1 mutations. What does this mean for women with breast cancer? …
Presented at SABCS 2022 by Len-Shu Lu from the National Taiwan University Hospital, Taipei Taiwan. Research remains an essential part of cancer care. In this blog, we will provide information about recent updates or new approvals as it applies to breast cancer written by Dr. Sharon Wilks. The use of CDK4/6 inhibitors has emerged as a valuable treatment in the …
Presented by Ruth O’ Regan et al. Research remains an essential part of cancer care. In this blog, we will provide information about recent updates or new approvals as it applies to breast cancer written by Dr. Sharon Wilks. This was a review of the tool called the Breast Cancer Index and its application for predicting the benefit of the …
Research remains an essential part of cancer care. In this blog, we will provide information about recent updates or new approvals as it applies to breast cancer written by Dr. Sharon Wilks. Educational Symposium on ADCs @ December 2022 SABCS. Bioengineering & Mechanism of Action of Antibody Drug Conjugates (ADC) Presentation from Puja Sapra, PhD with SVP Biologics Engineering and …
Research remains an essential part of cancer care. In this blog, we will provide information about recent updates or new approvals as it applies to breast cancer written by Dr. Sharon Wilks. POSITIVE TRIAL Pregnancy Outcome & Safety of Interrupting Therapy for Women with Endocrine ResponsIVE Breast Cancer. (Initial Results from the POSITIVE Trial presented by Ann Partridge Harvard Medical …
Research remains an essential part of cancer care. In this blog, we will provide information about recent updates or new approvals as it applies to breast cancer written by Dr. Sharon Wilks. For years, breast cancer treatments have been influenced by the information obtained at the time of the original biopsy of the breast cancer. When someone is diagnosed with …
Research remains an essential part of cancer care. In this blog, we will provide information about recent updates or new approvals as it applies to breast cancer written by Dr. Sharon Wilks. Recently, I attended two conferences about breast cancer, and both covered the special issue related to Pregnancy and Breast cancer. I think we are covering this issue more …
Research remains an essential part of cancer care. In this blog, we will provide information about recent updates or new approvals as it applies to breast cancer written by Dr. Sharon Wilks. How Long can you wait for Radiation after Surgery? Radiation treatment has remained an essential treatment particularly for those individuals who are at higher risk of breast cancer …
